Evidence map›Paper›PMID 28462039›Full record

ArticlePeerJ2017

Oxytetracycline induces DNA damage and epigenetic changes: a possible risk for human and animal health?

Adriana Gallo, Rosaria Landi, Valentina Rubino, Alessandro Di Cerbo, Angela Giovazzino, Anna Teresa Palatucci, Sara Centenaro, Gianandrea Guidetti, Sergio Canello, Laura Cortese and 3 more

Open access · goldAbstract read
In one paragraph

Article in PeerJ, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 35 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Toxins · 2023
    Article
  8. Article
  9. Article
  10. Biology · 2022
    Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Adriana Gallo *Institute of Experimental Endocrinology and Oncology (IEOS), National Research Council (CNR), Naples, Italy.
Rosaria Landi *Department of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Naples, Italy.
Valentina Rubino *Department of Translational Medical Sciences, University of Naples Federico II, Naples, Italy.
Alessandro Di CerboDepartment of Physics, Informatics and Mathematics, University of Modena and Reggio Emilia, Modena, Italy.
Angela GiovazzinoDepartment of Translational Medical Sciences, University of Naples Federico II, Naples, Italy.
Anna Teresa PalatucciPhD School of Science, University of Basilicata, Potenza, Italy.
Sara CentenaroDivision of Research and Development, Sanypet SpA, Padova, Italy.
Gianandrea GuidettiDivision of Research and Development, Sanypet SpA, Padova, Italy.
Sergio CanelloDivision of Research and Development, Sanypet SpA, Padova, Italy.
Laura CorteseDepartment of Veterinary Medicine and Animal Productions, University of Naples Federico II, Naples, Italy.
Giuseppina RuggieroDepartment of Translational Medical Sciences, University of Naples Federico II, Naples, Italy.
Andrea AlessandriniDepartment of Physics, Informatics and Mathematics, University of Modena and Reggio Emilia, Modena, Italy.
Giuseppe TerrazzanoDepartment of Translational Medical Sciences, University of Naples Federico II, Naples, Italy.
University of Naples Federico II · ITUniversity of Modena and Reggio Emilia · ITInstitute for Experimental Endocrinology and Oncology · ITUniversity of Basilicata · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOxytetracycline (OTC), which is largely employed in zootechnical and veterinary practices to ensure wellness of farmed animals, is partially absorbed within the gastrointestinal tract depositing in several tissues. Therefore, the potential OTC toxicity is relevant when considering the putative risk derived by the entry and accumulation of such drug in human and pet food chain supply. Despite scientific literature highlights several OTC-dependent toxic effects on human and animal health, the molecular mechanisms of such toxicity are still poorly understood.

methodsHere, we evaluated DNA damages and epigenetic alterations by quantitative reverse transcription polymerase chain reaction, quantitative polymerase chain reaction, chromatin immuno-precipitation and Western blot analysis.

resultsWe observed that human peripheral blood mononuclear cells (PBMCs) expressed DNA damage features (activation of ATM and p53, phosphorylation of H2AX and modifications of histone H3 methylation of lysine K4 in the chromatin) after the DISCUSSION: Our data reveal an unexpected biological

Indexed as

DNA damageDrug toxicityEpigeneticsImmune pharmacologyInflammatory response

Identifiers

PMID28462039
PMCPMC5410137
OpenAlexW2607738246

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.